NCT04080427View on ClinicalTrials.gov

Effects of Delta9-tetrahydrocannabinol (THC) on Retention of Memory for Fear Extinction Learning in PTSD: R33 Study

PHASE1CompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

April 15, 2021

Primary Completion Date

May 31, 2025

Study Completion Date

May 31, 2025

Conditions
Posttraumatic Stress Disorder
Interventions
DRUG

Placebo capsule

Placebo is administered just prior to weekly exposure sessions by the oral route and contains only dextrose in opaque capsules.

DRUG

Dronabinol 7.5 milligram oral capsule

Dronabinol (7.5mg) is administered just prior to weekly exposure sessions by the oral route and is placed in an opaque capsule with dextrose filler.

Trial Locations (1)

48201

Eugene Applebaum College of Pharmacy and Health Sciences, Detroit

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Wayne State University

OTHER